Braat, A. J. A. T., Kwekkeboom, D. J., Kam, B. L. R., Teunissen, J. J. M., de Herder, W. W., Dreijerink, K. M. A., . . . Lam, M. G. E. H. (2018). Additional hepatic (166)Ho-radioembolization in patients with neuroendocrine tumours treated with (177)Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial). BMC Gastroenterol.
Chicago Style aipamenaBraat, Arthur J. A. T., et al. "Additional Hepatic (166)Ho-radioembolization in Patients With Neuroendocrine Tumours Treated With (177)Lu-DOTATATE; a Single Center, Interventional, Non-randomized, Non-comparative, Open Label, Phase II Study (HEPAR PLUS Trial)." BMC Gastroenterol 2018.
MLA aipamenaBraat, Arthur J. A. T., et al. "Additional Hepatic (166)Ho-radioembolization in Patients With Neuroendocrine Tumours Treated With (177)Lu-DOTATATE; a Single Center, Interventional, Non-randomized, Non-comparative, Open Label, Phase II Study (HEPAR PLUS Trial)." BMC Gastroenterol 2018.